The aim of this study was to compare the fasting serum glucose level with the fasting plasma glucose level for diagnosing hyperglycemic states in real-life clinical situations. Additionally, we investigated a usual delay in sample processing and how such delays can impact the diagnosis of hyperglycemic states. Among 1,254 participants who had normoglycemia or impaired fasting glucose (IFG) assessed by the fasting serum glucose level, 20.9% were newly diagnosed with diabetes based on the plasma fasting glucose level. Of the participants with normoglycemia, 62.1% and 14.2% were newly diagnosed with IFG and diabetes, respectively, according to the plasma fasting glucose level. In our clinical laboratory for performing health examinations, the time delay from blood sampling to glycemic testing averaged 78±52 minutes. These findings show that the ordinary time delay for sample processing of the serum glucose for screening hyperglycemic states may be an important reason for these diagnoses to be underestimated in Korea.

Citations

Citations to this article as recorded by  

• Glucometer versus analyzer: comparable results with negligible clinical risk
  Alper Gümüş, Cihan Coşkun, Kamil Taha Uçar, İbrahim Erdin, Semih Tek, Betül Evran, Abdulkadir Çat, Oğuzhan Zengi
  Scandinavian Journal of Clinical and Laboratory Investigation.2025; 85(1): 11.     CrossRef
• Comparing glycemic traits in defining diabetes among rural Chinese older adults
  Pin Wang, Yuanjing Li, Mingqi Wang, Lin Song, Yi Dong, Xiaolei Han, Jaakko Tuomilehto, Yongxiang Wang, Yifeng Du, Chengxuan Qiu, Fredirick Lazaro mashili
  PLOS ONE.2024; 19(1): e0296694.     CrossRef
• An Overview of Pre-Analytical Factors Impacting Metabolomics Analyses of Blood Samples
  Amy Thachil, Li Wang, Rupasri Mandal, David Wishart, Tom Blydt-Hansen
  Metabolites.2024; 14(9): 474.     CrossRef
• Serum glucose, a cost-effective alternate of plasma glucose in diagnosing and monitoring diabetes mellitus
  Vivek Pant, Anders Kallner
  International Journal of Diabetes in Developing Countries.2023; 43(3): 377.     CrossRef
• Hyperglycemia and prematurity: a narrative review
  Dimitrios Angelis, Mambarambath A. Jaleel, Luc P. Brion
  Pediatric Research.2023; 94(3): 892.     CrossRef
• Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021
  Kanyin Liane Ong, Lauryn K Stafford, Susan A McLaughlin, Edward J Boyko, Stein Emil Vollset, Amanda E Smith, Bronte E Dalton, Joe Duprey, Jessica A Cruz, Hailey Hagins, Paulina A Lindstedt, Amirali Aali, Yohannes Habtegiorgis Abate, Melsew Dagne Abate, Mo
  The Lancet.2023; 402(10397): 203.     CrossRef
• PM2.5 exposure increases the risk of preterm birth in pre-pregnancy impaired fasting glucose women: A cohort study in a Southern province of China
  Zhijiang Liang, Lina Zhao, Jialing Qiu, Xinhong Zhu, Min Jiang, Guocheng Liu, Qingguo Zhao
  Environmental Research.2022; 204: 112403.     CrossRef
• The impact of maternal prepregnancy impaired fasting glucose on preterm birth and large for gestational age: a large population-based cohort study
  Jie Tang, Xinhong Zhu, Mingzhen Li, Dongming Huang, Qingguo Zhao
  American Journal of Obstetrics and Gynecology.2020; 222(3): 265.e1.     CrossRef
• Utility of point‐of‐care vs reference laboratory testing for the evaluation of glucose levels
  O. M. Andriankaja, F. J. Muñoz‐Torres, J. L. Vergara, C. M. Pérez, K. Joshipura
  Diabetic Medicine.2019; 36(5): 626.     CrossRef
• Pre-analytical factors in blood glucose measurement
  Alpesh Goyal, Yashdeep Gupta
  Diabetes Research and Clinical Practice.2019; 158: 107802.     CrossRef
• Long-term stability of glucose: glycolysis inhibitor vs. gel barrier tubes
  Theresa Winter, Anke Hannemann, Juliane Suchsland, Matthias Nauck, Astrid Petersmann
  Clinical Chemistry and Laboratory Medicine (CCLM).2018; 56(8): 1251.     CrossRef
• Blood Glucose Measurement: Is Serum Equal to Plasma?
  Hye Soon Kim
  Diabetes & Metabolism Journal.2016; 40(5): 365.     CrossRef

We aimed to estimate the threshold level of glycosylated hemoglobin (HbA1c) for the fasting plasma glucose of 100 and 126 mg/dL in the Korean adult population, using the 2011 Korea National Health and Nutrition Examination Survey. A total of 4,481 participants over 19 years of age without diabetic medications and conditions to influence the interpretation of HbA1c levels, such as anemia, renal insufficiency, liver cirrhosis, and cancers, were analyzed. A point-wise area under the receiver operating characteristic curve was used to estimate the optimal HbA1c cutoff value. A HbA1c threshold of 6.35% was optimal for predicting diabetes with a sensitivity of 86.9% and a specificity of 99.1%. Furthermore, the threshold of HbA1c was 5.65% for prediabetes, with a sensitivity of 69.3% and a specificity of 71%. Further prospective studies are needed to evaluate the HbA1c cutoff point for diagnosing prediabetes and diabetes in the Korean population.

Citations

Citations to this article as recorded by  

• The Cutoff Value of HbA1c in Predicting Diabetes and Impaired Fasting Glucose
  Seyoung Kwon, Youngak Na
  The Korean Journal of Clinical Laboratory Science.2017; 49(2): 114.     CrossRef
• Cutoff Point of HbA1c for Diagnosis of Diabetes Mellitus in Chinese Individuals
  Bing Wang, Ming-Chuan Liu, Xin-Yu Li, Xu-Han Liu, Qiu-Xia Feng, Lu Lu, Zhu Zhu, Ying-Shu Liu, Wei Zhao, Zheng-Nan Gao, Noel Christopher Barengo
  PLOS ONE.2016; 11(11): e0166597.     CrossRef